Trial Profile
Phase 2 Study of Weekly Topotecan With Docetaxel for Recurrent Small Cell Lung Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2023
Price :
$35
*
At a glance
- Drugs Topotecan (Primary) ; Docetaxel
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 12 Nov 2006 New trial record.